SNS Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $508K | Buy |
4,727
+17
| +0.4% | +$1.83K | 0.05% | 113 |
|
2025
Q1 | $475K | Buy |
4,710
+26
| +0.6% | +$2.62K | 0.05% | 117 |
|
2024
Q4 | $418K | Hold |
4,684
| – | – | 0.04% | 121 |
|
2024
Q3 | $393K | Buy |
4,684
+7
| +0.1% | +$587 | 0.04% | 129 |
|
2024
Q2 | $360K | Buy |
4,677
+12
| +0.3% | +$924 | 0.04% | 130 |
|
2024
Q1 | $320K | Buy |
4,665
+11
| +0.2% | +$753 | 0.04% | 144 |
|
2023
Q4 | $269K | Sell |
4,654
-42
| -0.9% | -$2.43K | 0.03% | 152 |
|
2023
Q3 | $248K | Buy |
4,696
+11
| +0.2% | +$581 | 0.03% | 154 |
|
2023
Q2 | $253K | Sell |
4,685
-9
| -0.2% | -$487 | 0.03% | 153 |
|
2023
Q1 | $235K | Buy |
4,694
+37
| +0.8% | +$1.85K | 0.03% | 162 |
|
2022
Q4 | $215K | Buy |
+4,657
| New | +$215K | 0.03% | 178 |
|
2022
Q2 | – | Sell |
-4,583
| Closed | -$203K | – | 196 |
|
2022
Q1 | $203K | Buy |
+4,583
| New | +$203K | 0.02% | 194 |
|
2020
Q1 | – | Sell |
-4,653
| Closed | -$211K | – | 168 |
|
2019
Q4 | $211K | Buy |
+4,653
| New | +$211K | 0.04% | 178 |
|
2018
Q4 | – | Sell |
-6,926
| Closed | -$267K | – | 183 |
|
2018
Q3 | $267K | Hold |
6,926
| – | – | 0.06% | 142 |
|
2018
Q2 | $226K | Buy |
+6,926
| New | +$226K | 0.06% | 150 |
|